GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 338 filers reported holding GUARDANT HEALTH INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $4,663,000 | -34.0% | 70,394 | -0.3% | 0.00% | -50.0% |
| Q4 2021 | $7,060,000 | -20.6% | 70,586 | -0.7% | 0.00% | -20.0% |
| Q3 2021 | $8,890,000 | -11.8% | 71,117 | -12.4% | 0.01% | -16.7% |
| Q2 2021 | $10,078,000 | -43.1% | 81,153 | -30.1% | 0.01% | -40.0% |
| Q1 2021 | $17,716,000 | +27.2% | 116,055 | +7.4% | 0.01% | +11.1% |
| Q4 2020 | $13,927,000 | +7.5% | 108,062 | -6.8% | 0.01% | 0.0% |
| Q3 2020 | $12,957,000 | +32.5% | 115,918 | -3.9% | 0.01% | +12.5% |
| Q2 2020 | $9,782,000 | +85.6% | 120,570 | +59.2% | 0.01% | +60.0% |
| Q1 2020 | $5,271,000 | -13.8% | 75,732 | -3.2% | 0.01% | +25.0% |
| Q4 2019 | $6,115,000 | +554.7% | 78,260 | +434.8% | 0.00% | +300.0% |
| Q3 2019 | $934,000 | -48.3% | 14,634 | -30.1% | 0.00% | 0.0% |
| Q2 2019 | $1,807,000 | +46.8% | 20,930 | +30.5% | 0.00% | 0.0% |
| Q1 2019 | $1,231,000 | +37.1% | 16,044 | -32.8% | 0.00% | 0.0% |
| Q4 2018 | $898,000 | – | 23,879 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |